During the past decade, University of California Davis Health conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California Davis Health" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "University of California, Davis" with 4 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "PTC Therapeutics" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California Davis Health" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Bowes Foundation" with 1 trials as a collaborator, "California Initiative to Advance Precision Medicine" with 1 trials as a collaborator, "Charles and Helen Schwab Foundation" with 1 trials as a collaborator and "Children's Hospital Colorado" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "University of California Davis Health" are "Alzheimer's Disease" (3 trials), "Duchenne Muscular Dystrophy" (2 trials), "Duchenne Muscular Dystrophy (DMD)" (2 trials), "Muscular Dystrophy, Duchenne" (2 trials) and "Primary Biliary Cholangitis" (2 trials). Many other conditions were trialed in "University of California Davis Health" in a lesser frequency.

Most popular intervention types in "University of California Davis Health" are "Drug" (33 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Abemaciclib" (4 trials), "placebo" (3 trials), "Ataluren" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of California Davis Health" are 37 trials for "All" genders, 7 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of California Davis Health". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in University of California Davis Health, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of California Davis Health, 7 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".